Docebo Inc.
NASDAQ:DCBOSoftware - Application
+$0.36 today
- Market cap
- $724.48M
- Beta
- 0.76
- P/E (TTM)
- 14.0
- EPS (TTM)
- $1.23
Volume 0.08M
Average 0.15M
DCBO Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Docebo Inc.NASDAQ: DCBO
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q1 FY2026 stock-based compensation was $0, compared with $789K a year earlier. Trailing-twelve-month stock-based compensation was $3.66M.
Context
- Stock-based compensation amounted to 0.0% of revenue in FY2025, down 3.4 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $914.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 7.33M | +21.2% |
| FY2023 | 2023-12-31 | 6.05M | +28.3% |
| FY2022 | 2022-12-31 | 4.71M | +108.4% |
| FY2021 | 2021-12-31 | 2.26M | — |
Stock-Based Compensation vs competitors
How DCBO compares with its peers on the latest reported figures
- DCBO's LTM Mar 2026 stock-based compensation of $3.66M is the smallest of the 3 companies compared; the peer median is $19.1M.
- Its year-over-year change of -40.9% is the lowest of 3, against a peer median of -28.8%.
- Stock-based compensation amounts to 1.5% of revenue for DCBO, versus a peer median of 8.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $26.2M | -30.3% | -16.2% | 14.5% | |
| LTM Apr 2026 | $12M | -27.3% | -28.8% | 2.5% | |
| LTM Mar 2026 | $3.66M | -40.9% | — | 1.5% | |
| Peer median (excluding DCBO) | $19.1M | -28.8% | -22.5% | 8.5% | |
Competitors are the stored peer set for DCBO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (13.6M) | 7.02M | 2.84M | 26.74M | 38.17M |
| Depreciation & Amortization | 2.02M | 2.33M | 3.14M | 3.38M | 3.24M |
| Deferred Income Tax | 172K | 764K | 2.01M | (3.02M) | 0 |
| Stock-Based Compensation | 2.26M | 4.71M | 6.05M | 7.33M | 0 |
| Change in Working Capital | 5.74M | 3.14M | 7.39M | 1.09M | (3.4M) |
| Accounts Receivables | (12.32M) | (8.88M) | (3.73M) | (4.47M) | (7.95M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | (1.38M) |
| Other Working Capital | 18.06M | 12.01M | 11.12M | 5.56M | 5.93M |
| Other Non-Cash Items | 153K | (15.68M) | (5.46M) | (6.27M) | (7.91M) |
| Operating Cash Flow | (3.25M) | 2.29M | 15.96M | 29.25M | 30.1M |
| Capital Expenditures | (1.15M) | (1.08M) | (635K) | (1.25M) | (998.17K) |
| Acquisitions (Net) | 0 | (1.16M) | (8.89M) | (250K) | (859K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (15.04K) |
| Investing Cash Flow | (1.15M) | (2.25M) | (9.52M) | (1.5M) | (1.87M) |
| Debt Repayment | (1.26M) | (1.25M) | (1.68M) | (1.89M) | (1.79M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 793.65K |
| Common Stock Repurchased | 0 | 0 | (159.45M) | (11.02M) | (47.87M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.68M | 2.92M | 10.12M | 6.07M | (31.25K) |
| Financing Cash Flow | 422K | 1.67M | (151M) | (6.84M) | (48.9M) |
| Effect of Forex Changes | (358K) | (745K) | 218K | (323K) | 2.09M |
| Net Change in Cash | (4.34M) | 970K | (144.34M) | 20.59M | (18.58M) |
| Free Cash Flow | (4.4M) | 1.21M | 15.33M | 28M | 29.1M |
Docebo Inc.
NASDAQ:DCBO
Intrinsic Alpha fair value
Locked
Current Price
$29.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.